Market Place
Sourcing Support
South Rampart Publishes SRP-001 Pain Mechanism, Phase 1 Data
16 May 2024 //
GLOBENEWSWIRE
South Rampart Pharma to Present at Biotech Showcase 2024
03 Jan 2024 //
PR NEWSWIRE
South Rampart Completes Phase 1 Study to Include Neuropathic Trials
02 Jan 2024 //
PR NEWSWIRE
South Rampart Expands Patent Portfolio with EU Approval for SRP-001
01 Nov 2023 //
PR NEWSWIRE
South Rampart Pharma Receives U.S. FDA Fast Track Designation for SRP-001
12 Oct 2023 //
PR NEWSWIRE
South Rampart Pharma to Participate in Upcoming Investor Events
10 Oct 2023 //
PR NEWSWIRE
South Rampart Pharma Awarded Second NIH Grant for Pilot Program
21 Sep 2023 //
PR NEWSWIRE
South Rampart Announces First Patient Enrolled in Dose Portion of Phase 1 Trial
22 Aug 2023 //
PR NEWSWIRE
South Rampart Pharma Further Expands Patent Portfolio for SRP-001
06 Jul 2023 //
PR NEWSWIRE
South Rampart Pharma to Present at 2023 BIO CEO & Investor Conference
31 Jan 2023 //
PR NEWSWIRE
South Rampart Announces Presentation at Arrowhead`s Pain Therapeutics Summit
21 Oct 2022 //
PRNEWSWIRE
South Rampart Pharma Issued Composition of Matter Patent for Treatment for Pain
04 Oct 2022 //
PRNEWSWIRE
South Rampart Receives Year 3 of NIH Fast-Track STTR Commercialization Grant
22 Sep 2022 //
PRNEWSWIRE
South Rampart Pharma Announces Late-Breaking Presentation at IASP 2022
25 Aug 2022 //
PRNEWSWIRE
South Rampart Pharma Appoints Josh Blacher as Chief Financial Officer
16 Aug 2022 //
PRNEWSWIRE
South Rampart Pharma Appoints Robert Dickey, MBA, as Chief Financial Officer
31 Mar 2022 //
ACCESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.